HPV vaccine may be cost-effective strategy for preventing oropharyngeal cancer in males
the ONA take:
According to a new study published online early in the journal Cancer, researchers from Princess Margaret Cancer Centre in Toronto, Ontario, Canada, have found that vaccinating adolescent boys against the human papillomavirus (HPV) may be a cost-effective approach for preventing squamous cell oropharyngeal cancer.
For the study, researchers applied a statistical model to a population of over 190,000 Canadian boys who were 12 years old in 2012. Results showed that the HPV vaccination could save $8 million to $28 million Canadian dollars over the boys' lifetimes.
The findings of this study are important because HPV-related oropharygneal cancer is projected to become the most common HPV-related cancer in the United States by 2020.
The authors of the study hope that the findings of this study will increase public awareness and persuade policymakers across the world to fund the HPV vaccination in boys.
HPV vaccinations, such as Gardasil, are known to be effective at reducing the risk of cervical, vulvar, vaginal, and anal cancer in females, and anal cancer in males.
HPV vaccine may be a cost-effective approach for preventing squamous cell oropharyngeal cancer.
Sign Up for Free e-newsletters
- Evolution of HER2-Positive Breast Cancer: Yesterday, Today, and Tomorrow
- Scalp Cooling With Dignicap May Reduce Alopecia During Chemotherapy for Breast Cancer
- Dedicated End-of-Life Education Program Improves Nurses' Care, Patient and Family Satisfaction
- Oncology Extended Care Clinic Reduced Urgent Cancer-Related ED Visits
- Reflexology, Aromatherapy May Reduce Pain, Anxiety of Brachytherapy for Cervical Cancer
- Hair Dyes and Cancer Risk (Fact Sheet)
- Taste Changes After Hematopoietic Stem Cell Transplant Affect QOL in Blood Cancers
- Hope, Optimism Reduce Psychological Distress in Advanced Cancer
- Mitomycin Extravasation Protocol
- Accurate Understanding of Capacity May Improve Workflow, Efficiency in Infusion Suite
- Nursing Practice Change Improved Chemo Administration, But Old Habits Die Hard
- Simple Adjustment Key to Paclitaxel Infusion Protocol That Reduced Hypersensitivity Reactions
- Online Program Aims to Assist With Clinical Trial Enrollment for Hematologic Cancers
- Education May Better Equip Nurses to Hold End-of-Life Conversations in Advanced Cancer
- Skipping the SICU Post Head and Neck Cancer Surgery May Improve Outcomes
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|